Pilot Gene Technology

China-based diagnostic reagents specialist, Pilot Gene Technology (Hangzhou) Co., Ltd, has reportedly raised RMB 100 million (USD 13.8 million) in a Series B financing round led by Simao Capital. The funds raised will be directed towards the research and development of fully automated instruments and equipment, including Point-of-Care Testing (POCT),…